L3VLUP
ProSign in

INSP · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

INSPLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • INSP
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterINSPLLY
Q3 20208 holders, $638m33 holders, $14.1bn
Q4 202010 holders, $936m29 holders, $17.3bn
Q1 202110 holders, $790m24 holders, $23.0bn
Q2 202111 holders, $277m24 holders, $27.8bn
Q3 202111 holders, $486m31 holders, $29.9bn
Q4 202110 holders, $282m31 holders, $34.7bn
Q1 202214 holders, $1.3bn24 holders, $35.3bn
Q2 202213 holders, $790m33 holders, $42.7bn
Q3 202214 holders, $436m31 holders, $43.4bn
Q4 202215 holders, $740m31 holders, $46.6bn
Q1 202315 holders, $738m33 holders, $44.3bn
Q2 202318 holders, $1.2bn37 holders, $59.6bn
Q3 202313 holders, $1.1bn44 holders, $67.6bn
Q4 202310 holders, $1.6bn45 holders, $73.6bn
Q1 20248 holders, $2.0bn41 holders, $95.3bn
Q2 20247 holders, $666m43 holders, $110bn
Q3 202411 holders, $1.6bn45 holders, $107bn
Q4 202411 holders, $1.2bn46 holders, $93.9bn
Q1 202510 holders, $627m42 holders, $98.4bn
Q2 20257 holders, $649m43 holders, $93.2bn
Q3 20258 holders, $232m39 holders, $86.7bn
Q4 202510 holders, $554m41 holders, $123bn
Q1 20264 holders, $199m39 holders, $106bn
Q2 20263 holders, $45m44 holders, $132bn
INSP

Inspire Med Sys Inc

Holders
11
Reported value
$1.2bn
Buyers
6
Sellers
6

Breadth 0 among 94 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
LLY

Eli Lilly & Co

Holders
46
Reported value
$93.9bn
Buyers
24
Sellers
23

Breadth +1 among 94 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q4 2024

Among the 50 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only INSP (4)

Baillie Gifford & Co, Dragoneer Investment Group LLC, ExodusPoint Capital Management LP, PDT Partners LLC

Only LLY (39)

Acadian Asset Management LLC, AllianceBernstein LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Citadel Advisors LLC, Coatue Management LLC, D. E. Shaw & Co., Dodge & Cox, Egerton Capital UK LLP, Eisler Capital Management Ltd, Freestone Grove Partners LP, GAMCO Investors Inc, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Lone Pine Capital LLC, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Polen Capital Management LLC, Quantbot Technologies LP, and 14 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →